Avidity Biosciences, Inc. (RNA)
72.92
+0.06
(+0.08%)
USD |
NASDAQ |
Feb 23, 16:00
72.92
0.00 (0.00%)
After-Hours: 19:59
Avidity Biosciences Profit Margin (Quarterly) : -1.40K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Dyne Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 10.70% |
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Insmed, Inc. | -124.5% |
| Sarepta Therapeutics, Inc. | -45.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.47% |
| Return on Assets | -33.66% |
| Return on Invested Capital | -37.09% |
| Gross Profit Margin (Quarterly) | 91.54% |
| Operating Margin (Quarterly) | -1.51K% |
| Return on Net Operating Assets | -1.19K% |